nodes	percent_of_prediction	percent_of_DWPC	metapath
Desmopressin—Nafarelin—Degarelix—prostate cancer	0.184	0.315	CrCrCtD
Desmopressin—Gonadorelin—Degarelix—prostate cancer	0.167	0.287	CrCrCtD
Desmopressin—PTGS2—prostate cancer	0.138	1	CbGaD
Desmopressin—Nafarelin—Goserelin—prostate cancer	0.122	0.209	CrCrCtD
Desmopressin—Gonadorelin—Goserelin—prostate cancer	0.111	0.19	CrCrCtD
Desmopressin—AVPR2—urine—prostate cancer	0.0117	0.554	CbGeAlD
Desmopressin—AVPR2—renal system—prostate cancer	0.00287	0.136	CbGeAlD
Desmopressin—PTGS1—prostate gland—prostate cancer	0.000769	0.0362	CbGeAlD
Desmopressin—PTGS2—prostate gland—prostate cancer	0.000735	0.0346	CbGeAlD
Desmopressin—PTGS1—seminal vesicle—prostate cancer	0.00065	0.0307	CbGeAlD
Desmopressin—PTGS2—seminal vesicle—prostate cancer	0.000621	0.0293	CbGeAlD
Desmopressin—PTGS1—epithelium—prostate cancer	0.000565	0.0266	CbGeAlD
Desmopressin—PTGS2—epithelium—prostate cancer	0.00054	0.0255	CbGeAlD
Desmopressin—PTGS1—renal system—prostate cancer	0.000524	0.0247	CbGeAlD
Desmopressin—PTGS2—renal system—prostate cancer	0.000501	0.0236	CbGeAlD
Desmopressin—PTGS2—urethra—prostate cancer	0.000492	0.0232	CbGeAlD
Desmopressin—PTGS2—bone marrow—prostate cancer	0.000379	0.0178	CbGeAlD
Desmopressin—PTGS2—Etoposide—prostate cancer	0.000352	0.542	CbGbCtD
Desmopressin—PTGS1—testis—prostate cancer	0.000339	0.016	CbGeAlD
Desmopressin—PTGS1—Etoposide—prostate cancer	0.000297	0.458	CbGbCtD
Desmopressin—PTGS1—lymph node—prostate cancer	0.000245	0.0116	CbGeAlD
Desmopressin—PTGS2—lymph node—prostate cancer	0.000235	0.0111	CbGeAlD
Desmopressin—Skin disorder—Capecitabine—prostate cancer	4.77e-05	0.000293	CcSEcCtD
Desmopressin—Sweating—Doxorubicin—prostate cancer	4.76e-05	0.000292	CcSEcCtD
Desmopressin—Urinary tract disorder—Epirubicin—prostate cancer	4.76e-05	0.000292	CcSEcCtD
Desmopressin—Hyperhidrosis—Capecitabine—prostate cancer	4.75e-05	0.000292	CcSEcCtD
Desmopressin—Oedema peripheral—Epirubicin—prostate cancer	4.74e-05	0.000291	CcSEcCtD
Desmopressin—Connective tissue disorder—Epirubicin—prostate cancer	4.73e-05	0.000291	CcSEcCtD
Desmopressin—Urethral disorder—Epirubicin—prostate cancer	4.72e-05	0.00029	CcSEcCtD
Desmopressin—Loss of consciousness—Prednisone—prostate cancer	4.71e-05	0.000289	CcSEcCtD
Desmopressin—Epistaxis—Doxorubicin—prostate cancer	4.68e-05	0.000288	CcSEcCtD
Desmopressin—Anorexia—Capecitabine—prostate cancer	4.68e-05	0.000288	CcSEcCtD
Desmopressin—Nausea—Estradiol—prostate cancer	4.68e-05	0.000287	CcSEcCtD
Desmopressin—Vomiting—Mitoxantrone—prostate cancer	4.67e-05	0.000287	CcSEcCtD
Desmopressin—Convulsion—Prednisone—prostate cancer	4.64e-05	0.000285	CcSEcCtD
Desmopressin—Visual impairment—Epirubicin—prostate cancer	4.64e-05	0.000285	CcSEcCtD
Desmopressin—Hypertension—Prednisone—prostate cancer	4.63e-05	0.000284	CcSEcCtD
Desmopressin—Rash—Mitoxantrone—prostate cancer	4.63e-05	0.000284	CcSEcCtD
Desmopressin—Dermatitis—Mitoxantrone—prostate cancer	4.62e-05	0.000284	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.62e-05	0.000284	CcSEcCtD
Desmopressin—Headache—Mitoxantrone—prostate cancer	4.6e-05	0.000282	CcSEcCtD
Desmopressin—Insomnia—Docetaxel—prostate cancer	4.59e-05	0.000282	CcSEcCtD
Desmopressin—Myalgia—Prednisone—prostate cancer	4.56e-05	0.00028	CcSEcCtD
Desmopressin—Paraesthesia—Docetaxel—prostate cancer	4.55e-05	0.00028	CcSEcCtD
Desmopressin—Anxiety—Prednisone—prostate cancer	4.55e-05	0.000279	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.53e-05	0.000278	CcSEcCtD
Desmopressin—Dyspnoea—Docetaxel—prostate cancer	4.52e-05	0.000278	CcSEcCtD
Desmopressin—Somnolence—Docetaxel—prostate cancer	4.51e-05	0.000277	CcSEcCtD
Desmopressin—Discomfort—Prednisone—prostate cancer	4.51e-05	0.000277	CcSEcCtD
Desmopressin—Eye disorder—Epirubicin—prostate cancer	4.5e-05	0.000276	CcSEcCtD
Desmopressin—Hypersensitivity—Etoposide—prostate cancer	4.5e-05	0.000276	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.47e-05	0.000275	CcSEcCtD
Desmopressin—Flushing—Epirubicin—prostate cancer	4.47e-05	0.000275	CcSEcCtD
Desmopressin—Cardiac disorder—Epirubicin—prostate cancer	4.47e-05	0.000275	CcSEcCtD
Desmopressin—Rhinitis—Doxorubicin—prostate cancer	4.47e-05	0.000274	CcSEcCtD
Desmopressin—Dyspepsia—Docetaxel—prostate cancer	4.46e-05	0.000274	CcSEcCtD
Desmopressin—Insomnia—Capecitabine—prostate cancer	4.44e-05	0.000273	CcSEcCtD
Desmopressin—Paraesthesia—Capecitabine—prostate cancer	4.41e-05	0.000271	CcSEcCtD
Desmopressin—Decreased appetite—Docetaxel—prostate cancer	4.41e-05	0.000271	CcSEcCtD
Desmopressin—Urinary tract disorder—Doxorubicin—prostate cancer	4.4e-05	0.00027	CcSEcCtD
Desmopressin—Oedema peripheral—Doxorubicin—prostate cancer	4.39e-05	0.00027	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Docetaxel—prostate cancer	4.38e-05	0.000269	CcSEcCtD
Desmopressin—Asthenia—Etoposide—prostate cancer	4.38e-05	0.000269	CcSEcCtD
Desmopressin—Connective tissue disorder—Doxorubicin—prostate cancer	4.38e-05	0.000269	CcSEcCtD
Desmopressin—Dyspnoea—Capecitabine—prostate cancer	4.38e-05	0.000269	CcSEcCtD
Desmopressin—Anaphylactic shock—Prednisone—prostate cancer	4.37e-05	0.000269	CcSEcCtD
Desmopressin—Oedema—Prednisone—prostate cancer	4.37e-05	0.000269	CcSEcCtD
Desmopressin—Fatigue—Docetaxel—prostate cancer	4.37e-05	0.000269	CcSEcCtD
Desmopressin—Angiopathy—Epirubicin—prostate cancer	4.37e-05	0.000268	CcSEcCtD
Desmopressin—Urethral disorder—Doxorubicin—prostate cancer	4.37e-05	0.000268	CcSEcCtD
Desmopressin—Nausea—Mitoxantrone—prostate cancer	4.36e-05	0.000268	CcSEcCtD
Desmopressin—Immune system disorder—Epirubicin—prostate cancer	4.35e-05	0.000267	CcSEcCtD
Desmopressin—Infection—Prednisone—prostate cancer	4.35e-05	0.000267	CcSEcCtD
Desmopressin—Mediastinal disorder—Epirubicin—prostate cancer	4.34e-05	0.000267	CcSEcCtD
Desmopressin—Pain—Docetaxel—prostate cancer	4.34e-05	0.000266	CcSEcCtD
Desmopressin—Constipation—Docetaxel—prostate cancer	4.34e-05	0.000266	CcSEcCtD
Desmopressin—Dyspepsia—Capecitabine—prostate cancer	4.32e-05	0.000266	CcSEcCtD
Desmopressin—Chills—Epirubicin—prostate cancer	4.32e-05	0.000265	CcSEcCtD
Desmopressin—Pruritus—Etoposide—prostate cancer	4.32e-05	0.000265	CcSEcCtD
Desmopressin—Shock—Prednisone—prostate cancer	4.3e-05	0.000264	CcSEcCtD
Desmopressin—Visual impairment—Doxorubicin—prostate cancer	4.29e-05	0.000264	CcSEcCtD
Desmopressin—Nervous system disorder—Prednisone—prostate cancer	4.29e-05	0.000264	CcSEcCtD
Desmopressin—Tachycardia—Prednisone—prostate cancer	4.27e-05	0.000262	CcSEcCtD
Desmopressin—Decreased appetite—Capecitabine—prostate cancer	4.27e-05	0.000262	CcSEcCtD
Desmopressin—Skin disorder—Prednisone—prostate cancer	4.25e-05	0.000261	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Capecitabine—prostate cancer	4.24e-05	0.00026	CcSEcCtD
Desmopressin—Fatigue—Capecitabine—prostate cancer	4.23e-05	0.00026	CcSEcCtD
Desmopressin—Hyperhidrosis—Prednisone—prostate cancer	4.23e-05	0.00026	CcSEcCtD
Desmopressin—Mental disorder—Epirubicin—prostate cancer	4.22e-05	0.000259	CcSEcCtD
Desmopressin—Pain—Capecitabine—prostate cancer	4.2e-05	0.000258	CcSEcCtD
Desmopressin—Constipation—Capecitabine—prostate cancer	4.2e-05	0.000258	CcSEcCtD
Desmopressin—Erythema—Epirubicin—prostate cancer	4.19e-05	0.000258	CcSEcCtD
Desmopressin—Malnutrition—Epirubicin—prostate cancer	4.19e-05	0.000258	CcSEcCtD
Desmopressin—Feeling abnormal—Docetaxel—prostate cancer	4.18e-05	0.000257	CcSEcCtD
Desmopressin—Diarrhoea—Etoposide—prostate cancer	4.18e-05	0.000257	CcSEcCtD
Desmopressin—Anorexia—Prednisone—prostate cancer	4.17e-05	0.000256	CcSEcCtD
Desmopressin—Eye disorder—Doxorubicin—prostate cancer	4.16e-05	0.000256	CcSEcCtD
Desmopressin—Gastrointestinal pain—Docetaxel—prostate cancer	4.15e-05	0.000255	CcSEcCtD
Desmopressin—Cardiac disorder—Doxorubicin—prostate cancer	4.13e-05	0.000254	CcSEcCtD
Desmopressin—Flushing—Doxorubicin—prostate cancer	4.13e-05	0.000254	CcSEcCtD
Desmopressin—Flatulence—Epirubicin—prostate cancer	4.13e-05	0.000254	CcSEcCtD
Desmopressin—Tension—Epirubicin—prostate cancer	4.11e-05	0.000253	CcSEcCtD
Desmopressin—Nervousness—Epirubicin—prostate cancer	4.07e-05	0.00025	CcSEcCtD
Desmopressin—Feeling abnormal—Capecitabine—prostate cancer	4.05e-05	0.000249	CcSEcCtD
Desmopressin—Angiopathy—Doxorubicin—prostate cancer	4.04e-05	0.000248	CcSEcCtD
Desmopressin—Dizziness—Etoposide—prostate cancer	4.04e-05	0.000248	CcSEcCtD
Desmopressin—Muscle spasms—Epirubicin—prostate cancer	4.03e-05	0.000248	CcSEcCtD
Desmopressin—Immune system disorder—Doxorubicin—prostate cancer	4.02e-05	0.000247	CcSEcCtD
Desmopressin—Gastrointestinal pain—Capecitabine—prostate cancer	4.02e-05	0.000247	CcSEcCtD
Desmopressin—Mediastinal disorder—Doxorubicin—prostate cancer	4.02e-05	0.000247	CcSEcCtD
Desmopressin—Abdominal pain—Docetaxel—prostate cancer	4.01e-05	0.000246	CcSEcCtD
Desmopressin—Body temperature increased—Docetaxel—prostate cancer	4.01e-05	0.000246	CcSEcCtD
Desmopressin—Chills—Doxorubicin—prostate cancer	4e-05	0.000246	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Prednisone—prostate cancer	3.99e-05	0.000245	CcSEcCtD
Desmopressin—Insomnia—Prednisone—prostate cancer	3.96e-05	0.000243	CcSEcCtD
Desmopressin—Paraesthesia—Prednisone—prostate cancer	3.93e-05	0.000241	CcSEcCtD
Desmopressin—Mental disorder—Doxorubicin—prostate cancer	3.9e-05	0.00024	CcSEcCtD
Desmopressin—Urticaria—Capecitabine—prostate cancer	3.9e-05	0.00024	CcSEcCtD
Desmopressin—Ill-defined disorder—Epirubicin—prostate cancer	3.89e-05	0.000239	CcSEcCtD
Desmopressin—Body temperature increased—Capecitabine—prostate cancer	3.88e-05	0.000238	CcSEcCtD
Desmopressin—Abdominal pain—Capecitabine—prostate cancer	3.88e-05	0.000238	CcSEcCtD
Desmopressin—Vomiting—Etoposide—prostate cancer	3.88e-05	0.000238	CcSEcCtD
Desmopressin—Erythema—Doxorubicin—prostate cancer	3.88e-05	0.000238	CcSEcCtD
Desmopressin—Malnutrition—Doxorubicin—prostate cancer	3.88e-05	0.000238	CcSEcCtD
Desmopressin—Agitation—Epirubicin—prostate cancer	3.85e-05	0.000237	CcSEcCtD
Desmopressin—Dyspepsia—Prednisone—prostate cancer	3.85e-05	0.000237	CcSEcCtD
Desmopressin—Rash—Etoposide—prostate cancer	3.85e-05	0.000236	CcSEcCtD
Desmopressin—Dermatitis—Etoposide—prostate cancer	3.84e-05	0.000236	CcSEcCtD
Desmopressin—Headache—Etoposide—prostate cancer	3.82e-05	0.000235	CcSEcCtD
Desmopressin—Flatulence—Doxorubicin—prostate cancer	3.82e-05	0.000235	CcSEcCtD
Desmopressin—Tension—Doxorubicin—prostate cancer	3.81e-05	0.000234	CcSEcCtD
Desmopressin—Decreased appetite—Prednisone—prostate cancer	3.8e-05	0.000234	CcSEcCtD
Desmopressin—Malaise—Epirubicin—prostate cancer	3.78e-05	0.000232	CcSEcCtD
Desmopressin—Fatigue—Prednisone—prostate cancer	3.77e-05	0.000232	CcSEcCtD
Desmopressin—Nervousness—Doxorubicin—prostate cancer	3.77e-05	0.000231	CcSEcCtD
Desmopressin—Vertigo—Epirubicin—prostate cancer	3.77e-05	0.000231	CcSEcCtD
Desmopressin—Syncope—Epirubicin—prostate cancer	3.76e-05	0.000231	CcSEcCtD
Desmopressin—Constipation—Prednisone—prostate cancer	3.74e-05	0.00023	CcSEcCtD
Desmopressin—Hypersensitivity—Docetaxel—prostate cancer	3.74e-05	0.00023	CcSEcCtD
Desmopressin—Muscle spasms—Doxorubicin—prostate cancer	3.73e-05	0.000229	CcSEcCtD
Desmopressin—Palpitations—Epirubicin—prostate cancer	3.7e-05	0.000228	CcSEcCtD
Desmopressin—Loss of consciousness—Epirubicin—prostate cancer	3.68e-05	0.000226	CcSEcCtD
Desmopressin—Cough—Epirubicin—prostate cancer	3.66e-05	0.000225	CcSEcCtD
Desmopressin—Asthenia—Docetaxel—prostate cancer	3.64e-05	0.000224	CcSEcCtD
Desmopressin—Convulsion—Epirubicin—prostate cancer	3.63e-05	0.000223	CcSEcCtD
Desmopressin—Nausea—Etoposide—prostate cancer	3.63e-05	0.000223	CcSEcCtD
Desmopressin—Hypertension—Epirubicin—prostate cancer	3.62e-05	0.000222	CcSEcCtD
Desmopressin—Hypersensitivity—Capecitabine—prostate cancer	3.62e-05	0.000222	CcSEcCtD
Desmopressin—Feeling abnormal—Prednisone—prostate cancer	3.6e-05	0.000221	CcSEcCtD
Desmopressin—Ill-defined disorder—Doxorubicin—prostate cancer	3.6e-05	0.000221	CcSEcCtD
Desmopressin—Pruritus—Docetaxel—prostate cancer	3.59e-05	0.00022	CcSEcCtD
Desmopressin—Gastrointestinal pain—Prednisone—prostate cancer	3.58e-05	0.00022	CcSEcCtD
Desmopressin—Myalgia—Epirubicin—prostate cancer	3.57e-05	0.000219	CcSEcCtD
Desmopressin—Chest pain—Epirubicin—prostate cancer	3.57e-05	0.000219	CcSEcCtD
Desmopressin—Agitation—Doxorubicin—prostate cancer	3.56e-05	0.000219	CcSEcCtD
Desmopressin—Anxiety—Epirubicin—prostate cancer	3.56e-05	0.000218	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.54e-05	0.000218	CcSEcCtD
Desmopressin—Discomfort—Epirubicin—prostate cancer	3.53e-05	0.000217	CcSEcCtD
Desmopressin—Asthenia—Capecitabine—prostate cancer	3.52e-05	0.000216	CcSEcCtD
Desmopressin—Malaise—Doxorubicin—prostate cancer	3.5e-05	0.000215	CcSEcCtD
Desmopressin—Vertigo—Doxorubicin—prostate cancer	3.48e-05	0.000214	CcSEcCtD
Desmopressin—Syncope—Doxorubicin—prostate cancer	3.48e-05	0.000214	CcSEcCtD
Desmopressin—Urticaria—Prednisone—prostate cancer	3.47e-05	0.000213	CcSEcCtD
Desmopressin—Pruritus—Capecitabine—prostate cancer	3.47e-05	0.000213	CcSEcCtD
Desmopressin—Diarrhoea—Docetaxel—prostate cancer	3.47e-05	0.000213	CcSEcCtD
Desmopressin—Abdominal pain—Prednisone—prostate cancer	3.46e-05	0.000212	CcSEcCtD
Desmopressin—Body temperature increased—Prednisone—prostate cancer	3.46e-05	0.000212	CcSEcCtD
Desmopressin—Confusional state—Epirubicin—prostate cancer	3.45e-05	0.000212	CcSEcCtD
Desmopressin—Palpitations—Doxorubicin—prostate cancer	3.43e-05	0.000211	CcSEcCtD
Desmopressin—Anaphylactic shock—Epirubicin—prostate cancer	3.42e-05	0.00021	CcSEcCtD
Desmopressin—Oedema—Epirubicin—prostate cancer	3.42e-05	0.00021	CcSEcCtD
Desmopressin—Loss of consciousness—Doxorubicin—prostate cancer	3.41e-05	0.000209	CcSEcCtD
Desmopressin—Infection—Epirubicin—prostate cancer	3.4e-05	0.000209	CcSEcCtD
Desmopressin—Cough—Doxorubicin—prostate cancer	3.38e-05	0.000208	CcSEcCtD
Desmopressin—Shock—Epirubicin—prostate cancer	3.37e-05	0.000207	CcSEcCtD
Desmopressin—Convulsion—Doxorubicin—prostate cancer	3.36e-05	0.000206	CcSEcCtD
Desmopressin—Diarrhoea—Capecitabine—prostate cancer	3.36e-05	0.000206	CcSEcCtD
Desmopressin—Nervous system disorder—Epirubicin—prostate cancer	3.35e-05	0.000206	CcSEcCtD
Desmopressin—Dizziness—Docetaxel—prostate cancer	3.35e-05	0.000206	CcSEcCtD
Desmopressin—Hypertension—Doxorubicin—prostate cancer	3.35e-05	0.000206	CcSEcCtD
Desmopressin—Tachycardia—Epirubicin—prostate cancer	3.34e-05	0.000205	CcSEcCtD
Desmopressin—Skin disorder—Epirubicin—prostate cancer	3.32e-05	0.000204	CcSEcCtD
Desmopressin—Hyperhidrosis—Epirubicin—prostate cancer	3.31e-05	0.000203	CcSEcCtD
Desmopressin—Chest pain—Doxorubicin—prostate cancer	3.3e-05	0.000203	CcSEcCtD
Desmopressin—Myalgia—Doxorubicin—prostate cancer	3.3e-05	0.000203	CcSEcCtD
Desmopressin—Anxiety—Doxorubicin—prostate cancer	3.29e-05	0.000202	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.28e-05	0.000201	CcSEcCtD
Desmopressin—Discomfort—Doxorubicin—prostate cancer	3.26e-05	0.0002	CcSEcCtD
Desmopressin—Anorexia—Epirubicin—prostate cancer	3.26e-05	0.0002	CcSEcCtD
Desmopressin—Dizziness—Capecitabine—prostate cancer	3.25e-05	0.0002	CcSEcCtD
Desmopressin—Vomiting—Docetaxel—prostate cancer	3.22e-05	0.000198	CcSEcCtD
Desmopressin—Hypersensitivity—Prednisone—prostate cancer	3.22e-05	0.000198	CcSEcCtD
Desmopressin—Rash—Docetaxel—prostate cancer	3.2e-05	0.000196	CcSEcCtD
Desmopressin—Dermatitis—Docetaxel—prostate cancer	3.2e-05	0.000196	CcSEcCtD
Desmopressin—Confusional state—Doxorubicin—prostate cancer	3.19e-05	0.000196	CcSEcCtD
Desmopressin—Headache—Docetaxel—prostate cancer	3.18e-05	0.000195	CcSEcCtD
Desmopressin—Anaphylactic shock—Doxorubicin—prostate cancer	3.17e-05	0.000194	CcSEcCtD
Desmopressin—Oedema—Doxorubicin—prostate cancer	3.17e-05	0.000194	CcSEcCtD
Desmopressin—Infection—Doxorubicin—prostate cancer	3.14e-05	0.000193	CcSEcCtD
Desmopressin—Asthenia—Prednisone—prostate cancer	3.14e-05	0.000193	CcSEcCtD
Desmopressin—Vomiting—Capecitabine—prostate cancer	3.12e-05	0.000192	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.12e-05	0.000191	CcSEcCtD
Desmopressin—Shock—Doxorubicin—prostate cancer	3.11e-05	0.000191	CcSEcCtD
Desmopressin—Nervous system disorder—Doxorubicin—prostate cancer	3.1e-05	0.000191	CcSEcCtD
Desmopressin—Rash—Capecitabine—prostate cancer	3.1e-05	0.00019	CcSEcCtD
Desmopressin—Pruritus—Prednisone—prostate cancer	3.09e-05	0.00019	CcSEcCtD
Desmopressin—Insomnia—Epirubicin—prostate cancer	3.09e-05	0.00019	CcSEcCtD
Desmopressin—Dermatitis—Capecitabine—prostate cancer	3.09e-05	0.00019	CcSEcCtD
Desmopressin—Tachycardia—Doxorubicin—prostate cancer	3.09e-05	0.00019	CcSEcCtD
Desmopressin—Headache—Capecitabine—prostate cancer	3.08e-05	0.000189	CcSEcCtD
Desmopressin—Skin disorder—Doxorubicin—prostate cancer	3.07e-05	0.000189	CcSEcCtD
Desmopressin—Paraesthesia—Epirubicin—prostate cancer	3.07e-05	0.000189	CcSEcCtD
Desmopressin—Hyperhidrosis—Doxorubicin—prostate cancer	3.06e-05	0.000188	CcSEcCtD
Desmopressin—Dyspnoea—Epirubicin—prostate cancer	3.05e-05	0.000187	CcSEcCtD
Desmopressin—Somnolence—Epirubicin—prostate cancer	3.04e-05	0.000187	CcSEcCtD
Desmopressin—Anorexia—Doxorubicin—prostate cancer	3.02e-05	0.000185	CcSEcCtD
Desmopressin—Nausea—Docetaxel—prostate cancer	3.01e-05	0.000185	CcSEcCtD
Desmopressin—Dyspepsia—Epirubicin—prostate cancer	3.01e-05	0.000185	CcSEcCtD
Desmopressin—Diarrhoea—Prednisone—prostate cancer	2.99e-05	0.000184	CcSEcCtD
Desmopressin—Decreased appetite—Epirubicin—prostate cancer	2.97e-05	0.000183	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Epirubicin—prostate cancer	2.95e-05	0.000181	CcSEcCtD
Desmopressin—Fatigue—Epirubicin—prostate cancer	2.95e-05	0.000181	CcSEcCtD
Desmopressin—Pain—Epirubicin—prostate cancer	2.93e-05	0.00018	CcSEcCtD
Desmopressin—Constipation—Epirubicin—prostate cancer	2.93e-05	0.00018	CcSEcCtD
Desmopressin—Nausea—Capecitabine—prostate cancer	2.92e-05	0.000179	CcSEcCtD
Desmopressin—Dizziness—Prednisone—prostate cancer	2.89e-05	0.000178	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.88e-05	0.000177	CcSEcCtD
Desmopressin—Insomnia—Doxorubicin—prostate cancer	2.86e-05	0.000176	CcSEcCtD
Desmopressin—Paraesthesia—Doxorubicin—prostate cancer	2.84e-05	0.000175	CcSEcCtD
Desmopressin—Dyspnoea—Doxorubicin—prostate cancer	2.82e-05	0.000173	CcSEcCtD
Desmopressin—Feeling abnormal—Epirubicin—prostate cancer	2.82e-05	0.000173	CcSEcCtD
Desmopressin—Somnolence—Doxorubicin—prostate cancer	2.81e-05	0.000173	CcSEcCtD
Desmopressin—Gastrointestinal pain—Epirubicin—prostate cancer	2.8e-05	0.000172	CcSEcCtD
Desmopressin—Dyspepsia—Doxorubicin—prostate cancer	2.79e-05	0.000171	CcSEcCtD
Desmopressin—Vomiting—Prednisone—prostate cancer	2.78e-05	0.000171	CcSEcCtD
Desmopressin—Rash—Prednisone—prostate cancer	2.76e-05	0.000169	CcSEcCtD
Desmopressin—Dermatitis—Prednisone—prostate cancer	2.76e-05	0.000169	CcSEcCtD
Desmopressin—Decreased appetite—Doxorubicin—prostate cancer	2.75e-05	0.000169	CcSEcCtD
Desmopressin—Headache—Prednisone—prostate cancer	2.74e-05	0.000168	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.73e-05	0.000168	CcSEcCtD
Desmopressin—Fatigue—Doxorubicin—prostate cancer	2.73e-05	0.000168	CcSEcCtD
Desmopressin—Urticaria—Epirubicin—prostate cancer	2.72e-05	0.000167	CcSEcCtD
Desmopressin—Constipation—Doxorubicin—prostate cancer	2.71e-05	0.000166	CcSEcCtD
Desmopressin—Pain—Doxorubicin—prostate cancer	2.71e-05	0.000166	CcSEcCtD
Desmopressin—Abdominal pain—Epirubicin—prostate cancer	2.7e-05	0.000166	CcSEcCtD
Desmopressin—Body temperature increased—Epirubicin—prostate cancer	2.7e-05	0.000166	CcSEcCtD
Desmopressin—Feeling abnormal—Doxorubicin—prostate cancer	2.61e-05	0.00016	CcSEcCtD
Desmopressin—Nausea—Prednisone—prostate cancer	2.6e-05	0.00016	CcSEcCtD
Desmopressin—Gastrointestinal pain—Doxorubicin—prostate cancer	2.59e-05	0.000159	CcSEcCtD
Desmopressin—Hypersensitivity—Epirubicin—prostate cancer	2.52e-05	0.000155	CcSEcCtD
Desmopressin—Urticaria—Doxorubicin—prostate cancer	2.51e-05	0.000154	CcSEcCtD
Desmopressin—Abdominal pain—Doxorubicin—prostate cancer	2.5e-05	0.000154	CcSEcCtD
Desmopressin—Body temperature increased—Doxorubicin—prostate cancer	2.5e-05	0.000154	CcSEcCtD
Desmopressin—Asthenia—Epirubicin—prostate cancer	2.45e-05	0.000151	CcSEcCtD
Desmopressin—Pruritus—Epirubicin—prostate cancer	2.42e-05	0.000149	CcSEcCtD
Desmopressin—Diarrhoea—Epirubicin—prostate cancer	2.34e-05	0.000144	CcSEcCtD
Desmopressin—Hypersensitivity—Doxorubicin—prostate cancer	2.33e-05	0.000143	CcSEcCtD
Desmopressin—Asthenia—Doxorubicin—prostate cancer	2.27e-05	0.00014	CcSEcCtD
Desmopressin—Dizziness—Epirubicin—prostate cancer	2.26e-05	0.000139	CcSEcCtD
Desmopressin—Pruritus—Doxorubicin—prostate cancer	2.24e-05	0.000138	CcSEcCtD
Desmopressin—Vomiting—Epirubicin—prostate cancer	2.18e-05	0.000134	CcSEcCtD
Desmopressin—Diarrhoea—Doxorubicin—prostate cancer	2.17e-05	0.000133	CcSEcCtD
Desmopressin—Rash—Epirubicin—prostate cancer	2.16e-05	0.000133	CcSEcCtD
Desmopressin—Dermatitis—Epirubicin—prostate cancer	2.16e-05	0.000132	CcSEcCtD
Desmopressin—Headache—Epirubicin—prostate cancer	2.14e-05	0.000132	CcSEcCtD
Desmopressin—Dizziness—Doxorubicin—prostate cancer	2.09e-05	0.000129	CcSEcCtD
Desmopressin—Nausea—Epirubicin—prostate cancer	2.03e-05	0.000125	CcSEcCtD
Desmopressin—Vomiting—Doxorubicin—prostate cancer	2.01e-05	0.000124	CcSEcCtD
Desmopressin—Rash—Doxorubicin—prostate cancer	2e-05	0.000123	CcSEcCtD
Desmopressin—Dermatitis—Doxorubicin—prostate cancer	1.99e-05	0.000123	CcSEcCtD
Desmopressin—Headache—Doxorubicin—prostate cancer	1.98e-05	0.000122	CcSEcCtD
Desmopressin—Nausea—Doxorubicin—prostate cancer	1.88e-05	0.000116	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—PIK3CD—prostate cancer	9.89e-06	0.000105	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MAP2K1—prostate cancer	9.89e-06	0.000105	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—HPGDS—prostate cancer	9.86e-06	0.000104	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PIK3CD—prostate cancer	9.82e-06	0.000104	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	9.82e-06	0.000104	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—PIK3CA—prostate cancer	9.8e-06	0.000104	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP2C19—prostate cancer	9.8e-06	0.000104	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GSTO1—prostate cancer	9.79e-06	0.000104	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—HSD3B2—prostate cancer	9.79e-06	0.000104	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NAT2—prostate cancer	9.79e-06	0.000104	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—SERPINE1—prostate cancer	9.79e-06	0.000104	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—PIK3CA—prostate cancer	9.73e-06	0.000103	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—SERPINE1—prostate cancer	9.72e-06	0.000103	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—VEGFA—prostate cancer	9.71e-06	0.000103	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—KRAS—prostate cancer	9.69e-06	0.000103	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—KRAS—prostate cancer	9.62e-06	0.000102	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—STAT3—prostate cancer	9.61e-06	0.000102	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ACHE—prostate cancer	9.56e-06	0.000101	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GSTT1—prostate cancer	9.56e-06	0.000101	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—FGF2—prostate cancer	9.47e-06	0.0001	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP2A6—prostate cancer	9.45e-06	0.0001	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	9.42e-06	9.98e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	9.42e-06	9.98e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—FGF2—prostate cancer	9.41e-06	9.96e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PLCB2—prostate cancer	9.39e-06	9.95e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—LRP2—prostate cancer	9.39e-06	9.95e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP2C18—prostate cancer	9.39e-06	9.95e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—NOS3—prostate cancer	9.34e-06	9.9e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—NOS3—prostate cancer	9.28e-06	9.83e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—P4HB—prostate cancer	9.21e-06	9.75e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—AKR1C3—prostate cancer	9.2e-06	9.74e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PRKACB—prostate cancer	9.15e-06	9.69e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—JAK2—prostate cancer	9.08e-06	9.62e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP17A1—prostate cancer	9.05e-06	9.59e-05	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	9.02e-06	9.56e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—JAK2—prostate cancer	9.01e-06	9.55e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—SLC22A1—prostate cancer	8.96e-06	9.49e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—MYC—prostate cancer	8.93e-06	9.47e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	8.93e-06	9.46e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TGFB1—prostate cancer	8.91e-06	9.44e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—PIK3CA—prostate cancer	8.9e-06	9.43e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MDM2—prostate cancer	8.86e-06	9.39e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TGFBR1—prostate cancer	8.86e-06	9.39e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—B2M—prostate cancer	8.86e-06	9.39e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	8.85e-06	9.38e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—PIK3CA—prostate cancer	8.84e-06	9.36e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MDM2—prostate cancer	8.8e-06	9.32e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—ERBB2—prostate cancer	8.74e-06	9.26e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—EGFR—prostate cancer	8.74e-06	9.26e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—SULT2A1—prostate cancer	8.73e-06	9.25e-05	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	8.73e-06	9.24e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—RPS19—prostate cancer	8.72e-06	9.24e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—AKR1C3—prostate cancer	8.72e-06	9.24e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—ERBB2—prostate cancer	8.68e-06	9.19e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PRKACB—prostate cancer	8.67e-06	9.19e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NCOA2—prostate cancer	8.63e-06	9.14e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PIK3CB—prostate cancer	8.62e-06	9.14e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—MED12—prostate cancer	8.59e-06	9.1e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PIK3CB—prostate cancer	8.56e-06	9.07e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GNG5—prostate cancer	8.52e-06	9.02e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PPP3CA—prostate cancer	8.45e-06	8.96e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CXCL8—prostate cancer	8.29e-06	8.78e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—KRAS—prostate cancer	8.26e-06	8.75e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—SLC5A5—prostate cancer	8.23e-06	8.72e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CXCL8—prostate cancer	8.23e-06	8.72e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NCOA3—prostate cancer	8.21e-06	8.69e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PRKCZ—prostate cancer	8.18e-06	8.66e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CDKN1B—prostate cancer	8.09e-06	8.57e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	8.06e-06	8.54e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP2E1—prostate cancer	8.04e-06	8.52e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CDKN1B—prostate cancer	8.03e-06	8.51e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CALR—prostate cancer	8.03e-06	8.51e-05	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—AKT1—prostate cancer	8.01e-06	8.48e-05	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—AKT1—prostate cancer	7.95e-06	8.42e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NQO1—prostate cancer	7.95e-06	8.42e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CASP3—prostate cancer	7.93e-06	8.4e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—IL2—prostate cancer	7.92e-06	8.39e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FGFR4—prostate cancer	7.9e-06	8.37e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PARP1—prostate cancer	7.9e-06	8.37e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—IL6—prostate cancer	7.88e-06	8.35e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CASP3—prostate cancer	7.87e-06	8.34e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—IL2—prostate cancer	7.86e-06	8.33e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—TH—prostate cancer	7.83e-06	8.3e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—HPGDS—prostate cancer	7.83e-06	8.29e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—IL6—prostate cancer	7.82e-06	8.29e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CALCA—prostate cancer	7.8e-06	8.26e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	7.78e-06	8.25e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP2C19—prostate cancer	7.78e-06	8.24e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP3A4—prostate cancer	7.75e-06	8.21e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CCND1—prostate cancer	7.72e-06	8.18e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	7.71e-06	8.17e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CCND1—prostate cancer	7.67e-06	8.12e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CTNNB1—prostate cancer	7.65e-06	8.1e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP1B1—prostate cancer	7.62e-06	8.07e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GSTT1—prostate cancer	7.59e-06	8.04e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ACHE—prostate cancer	7.59e-06	8.04e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CTNNB1—prostate cancer	7.59e-06	8.04e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—PIK3CA—prostate cancer	7.58e-06	8.04e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP2A6—prostate cancer	7.5e-06	7.95e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MMP9—prostate cancer	7.5e-06	7.94e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HSPA1A—prostate cancer	7.48e-06	7.92e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	7.48e-06	7.92e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CDKN1A—prostate cancer	7.47e-06	7.91e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PTEN—prostate cancer	7.45e-06	7.9e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MMP9—prostate cancer	7.44e-06	7.88e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CDKN1A—prostate cancer	7.42e-06	7.86e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PTEN—prostate cancer	7.4e-06	7.84e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GGT1—prostate cancer	7.38e-06	7.82e-05	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	7.37e-06	7.81e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TP53—prostate cancer	7.34e-06	7.77e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—AKR1C3—prostate cancer	7.3e-06	7.73e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—AKT1—prostate cancer	7.27e-06	7.7e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NCOA1—prostate cancer	7.27e-06	7.7e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PRKACB—prostate cancer	7.26e-06	7.69e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—AKT1—prostate cancer	7.22e-06	7.65e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP17A1—prostate cancer	7.19e-06	7.61e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CASP9—prostate cancer	7.18e-06	7.6e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP19A1—prostate cancer	7.16e-06	7.59e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—EP300—prostate cancer	7.11e-06	7.53e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	7.09e-06	7.51e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—EP300—prostate cancer	7.06e-06	7.48e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PRKCQ—prostate cancer	6.95e-06	7.37e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—RXRA—prostate cancer	6.91e-06	7.33e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—SRC—prostate cancer	6.91e-06	7.32e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—SRC—prostate cancer	6.86e-06	7.27e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NCOA2—prostate cancer	6.85e-06	7.26e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—VEGFA—prostate cancer	6.73e-06	7.13e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	6.73e-06	7.13e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—IL6—prostate cancer	6.72e-06	7.12e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—VEGFA—prostate cancer	6.68e-06	7.08e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—STAT3—prostate cancer	6.66e-06	7.06e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—COMT—prostate cancer	6.66e-06	7.06e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GSTP1—prostate cancer	6.63e-06	7.02e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—STAT3—prostate cancer	6.62e-06	7.01e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FGF10—prostate cancer	6.61e-06	7e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—SLC5A5—prostate cancer	6.53e-06	6.92e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ITPR1—prostate cancer	6.52e-06	6.91e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.41e-06	6.8e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP2E1—prostate cancer	6.38e-06	6.76e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NQO1—prostate cancer	6.31e-06	6.68e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TGFBR2—prostate cancer	6.28e-06	6.66e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—TH—prostate cancer	6.22e-06	6.59e-05	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—AKT1—prostate cancer	6.2e-06	6.56e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MYC—prostate cancer	6.19e-06	6.56e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ITPR1—prostate cancer	6.18e-06	6.55e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.18e-06	6.55e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TGFB1—prostate cancer	6.18e-06	6.55e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—TYMS—prostate cancer	6.16e-06	6.53e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP3A4—prostate cancer	6.15e-06	6.52e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MYC—prostate cancer	6.15e-06	6.51e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TGFB1—prostate cancer	6.13e-06	6.5e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GSTM1—prostate cancer	6.09e-06	6.45e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—EGFR—prostate cancer	6.06e-06	6.42e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP1B1—prostate cancer	6.05e-06	6.41e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—EGFR—prostate cancer	6.01e-06	6.37e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—LPL—prostate cancer	5.98e-06	6.34e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GGT1—prostate cancer	5.86e-06	6.21e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP1A1—prostate cancer	5.77e-06	6.12e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NCOA1—prostate cancer	5.77e-06	6.11e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ERCC2—prostate cancer	5.73e-06	6.07e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—KRAS—prostate cancer	5.72e-06	6.06e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP19A1—prostate cancer	5.69e-06	6.03e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—KRAS—prostate cancer	5.68e-06	6.02e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—LPL—prostate cancer	5.67e-06	6.01e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PDGFRB—prostate cancer	5.62e-06	5.95e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—RXRA—prostate cancer	5.49e-06	5.82e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ERCC2—prostate cancer	5.43e-06	5.75e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—MTHFR—prostate cancer	5.38e-06	5.7e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.34e-06	5.66e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ERBB3—prostate cancer	5.31e-06	5.63e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FGFR2—prostate cancer	5.3e-06	5.62e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—COMT—prostate cancer	5.29e-06	5.6e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PPARA—prostate cancer	5.28e-06	5.6e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GSTP1—prostate cancer	5.26e-06	5.58e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PIK3CA—prostate cancer	5.26e-06	5.57e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PIK3CA—prostate cancer	5.22e-06	5.53e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ITPR1—prostate cancer	5.18e-06	5.49e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MTHFR—prostate cancer	5.1e-06	5.41e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.09e-06	5.39e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TERT—prostate cancer	5.09e-06	5.39e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TP53—prostate cancer	5.09e-06	5.39e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TP53—prostate cancer	5.05e-06	5.35e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CAV1—prostate cancer	4.97e-06	5.26e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—TYMS—prostate cancer	4.89e-06	5.18e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HIF1A—prostate cancer	4.87e-06	5.16e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GSTM1—prostate cancer	4.84e-06	5.12e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—LPL—prostate cancer	4.75e-06	5.03e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.74e-06	5.03e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CAV1—prostate cancer	4.71e-06	4.99e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—IL6—prostate cancer	4.66e-06	4.93e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—IL6—prostate cancer	4.62e-06	4.9e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP1A1—prostate cancer	4.58e-06	4.86e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ERCC2—prostate cancer	4.55e-06	4.82e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PIK3CG—prostate cancer	4.52e-06	4.79e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—BAD—prostate cancer	4.43e-06	4.69e-05	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—AKT1—prostate cancer	4.29e-06	4.55e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—APC—prostate cancer	4.29e-06	4.54e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—INS—prostate cancer	4.28e-06	4.54e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—MTHFR—prostate cancer	4.27e-06	4.53e-05	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—AKT1—prostate cancer	4.26e-06	4.52e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—EGF—prostate cancer	4.24e-06	4.49e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—IRS1—prostate cancer	4.24e-06	4.49e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CREBBP—prostate cancer	4.19e-06	4.44e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PPARA—prostate cancer	4.19e-06	4.44e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—GSK3B—prostate cancer	4.11e-06	4.36e-05	CbGpPWpGaD
Desmopressin—Octreotide—MPO—prostate cancer	4.09e-06	1	CrCbGaD
Desmopressin—PTGS2—Disease—INS—prostate cancer	4.06e-06	4.3e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PIK3CD—prostate cancer	3.98e-06	4.21e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CREBBP—prostate cancer	3.98e-06	4.21e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CAV1—prostate cancer	3.94e-06	4.18e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MAP2K1—prostate cancer	3.79e-06	4.02e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PIK3CD—prostate cancer	3.77e-06	3.99e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.77e-06	3.99e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NOS3—prostate cancer	3.75e-06	3.98e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—SERPINE1—prostate cancer	3.73e-06	3.95e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FGF2—prostate cancer	3.61e-06	3.82e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PIK3CG—prostate cancer	3.59e-06	3.8e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NOS3—prostate cancer	3.56e-06	3.77e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PIK3CB—prostate cancer	3.47e-06	3.67e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—JAK2—prostate cancer	3.46e-06	3.67e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PTGS2—prostate cancer	3.43e-06	3.64e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—INS—prostate cancer	3.4e-06	3.6e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MDM2—prostate cancer	3.38e-06	3.58e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CREBBP—prostate cancer	3.33e-06	3.53e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ERBB2—prostate cancer	3.33e-06	3.53e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PIK3CB—prostate cancer	3.29e-06	3.48e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PIK3CD—prostate cancer	3.16e-06	3.34e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CDKN1B—prostate cancer	3.08e-06	3.27e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PTEN—prostate cancer	3e-06	3.17e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NOS3—prostate cancer	2.98e-06	3.16e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CTNNB1—prostate cancer	2.91e-06	3.09e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—EP300—prostate cancer	2.86e-06	3.03e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CDKN1A—prostate cancer	2.85e-06	3.01e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PTEN—prostate cancer	2.84e-06	3.01e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PIK3CB—prostate cancer	2.75e-06	2.92e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—EP300—prostate cancer	2.71e-06	2.87e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—SRC—prostate cancer	2.63e-06	2.79e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—STAT3—prostate cancer	2.54e-06	2.69e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PTEN—prostate cancer	2.38e-06	2.52e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MYC—prostate cancer	2.36e-06	2.5e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TGFB1—prostate cancer	2.35e-06	2.49e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—EGFR—prostate cancer	2.31e-06	2.44e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—EP300—prostate cancer	2.27e-06	2.4e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—KRAS—prostate cancer	2.18e-06	2.31e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PIK3CA—prostate cancer	2.11e-06	2.24e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PIK3CA—prostate cancer	2e-06	2.12e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—IL6—prostate cancer	1.77e-06	1.88e-05	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—AKT1—prostate cancer	1.73e-06	1.83e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PIK3CA—prostate cancer	1.68e-06	1.78e-05	CbGpPWpGaD
Desmopressin—PTGS2—Disease—AKT1—prostate cancer	1.64e-06	1.73e-05	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—AKT1—prostate cancer	1.37e-06	1.45e-05	CbGpPWpGaD
